By Ashley Zborowski, Director of Business Development, LSN
The Redefining Early Stage Investment (RESI) Service Provider Showcase helps companies gain unprecedented visibility into the early-stage life science community and leverages Life Science Nation (LSN)’s close-knit network of key decision-makers to make promising connections with future clients. Service providers are an important asset in the fundraising ecosystem, and this new program is designed to increase their exposure to the RESI community.
Digital RESI, June 8-10, proudly features service providers advancing early-stage startups within drugs, devices, diagnostics, and digital health. Often the unsung heroes of fundraising startups, these powerful partnerships are essential in commercializing, building teams, conducting research, manufacturing, and so much more! Meet and get to know some featured service providers at Digital RESI June, and contact us to learn more about this special offer.
MERIT is an innovative specialty CRO providing clinical trial data collection and interpretation in the ophthalmology and respiratory disciplines. Our portfolio of solutions offers deep clinical expertise, unique technology, and exceptional service for our partners, sponsors, and CROs.
At PharmaDirections, gain access to top talent without the cost or risk of a full-time, in-house team. More than just a consultant or outside vendor, we are an extension of your team and are accountable for all aspects of a project, from discovery to regulatory approval.
SPH Phililab an innovation pharmaceutical company that develop, registrar, and manufacture generic and modified new drug product in USA and China. Our product portfolio focuses on the two largest pharmaceutical markets in the world, plus our unique background of management team and scientists made us a pioneer as an international player in the pharmaceutical industry.
Next Phase Newsletter 
Leave a Reply